Skip to Content

Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Treosulfan Based Preparative Regimen

Objective
This is a clinical trial treosulfan, fludarabine, and low dose radiation before cord blood transplant. Treosulfan and fludarabine will be administered by a central venous catheter.
IRB Protocol Number
09-0817
Principal Investigator(s)
JONATHAN GUTMAN

Cancer Trials

  • Blood Diseases (Except Leukemia)
Sponsor(s)
Fred Hutchinson Cancer Research Center
Contact
NICOLE AYODEJI at 720-848-0701
or NICOLE.AYODEJI@UCDENVER.EDU
Eligibility and Other Participant Information
What To Expect : A screening period to determine eligibility. A treatment period and a follow up period that will consist of clinic visits. // Eligibility criteria will include but are not limited to 18 years or older and eligible for cord blood transplant.